Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

 « Previous 10 Page of 27 Next 10 »

Washington, Caron inducted into American Academy of Arts and Sciences

Two members of the Duke community have been inducted as members of the American Academy of Arts and Sciences, one of the nation’s oldest learned societies and independent policy research centers.

Monkey model discovery could spur CMV vaccine development

Cytomegalovirus (CMV) is the leading infectious cause of birth defects worldwide, but scientists have been frustrated in their efforts to develop a vaccine to protect against infections.

Duke launches autism app with global reach

A team of researchers and software developers from Duke University and the Duke Medical Center has introduced a free iOS app to learn more about autism in young children living around the world.

Drug-resistant E. coli continues to climb in community health settings

Drug-resistant E. coli infections are on the rise in community hospitals, where more than half of U.S. patients receive their health care, according to a new study from Duke Medicine.

DCIS Treatments Evolve Over 20 Years, But Cancer Death Rates Vary Little

Treatment patterns for ductal carcinoma in situ (DCIS) have shifted since the 1990s, with more U.S. women opting for lumpectomy in combination with radiation rather than single-breast mastectomy, according to a study lead by Duke Cancer Institute researchers.

Cleaning Hospital Rooms With Chemicals, UV Rays Cuts Superbug Transmissions

In a hospital, what you can’t see could hurt you.

Paul Modrich Shares Nobel Prize in Chemistry for Work in DNA Repair

Paul Modrich, Ph.D., the James B. Duke professor of biochemistry in the Duke University School of Medicine, has been awarded one-third of this year’s Nobel Prize in Chemistry for his four decades of work on how mistakes in the DNA code are repaired.

Duke Establishes First Hand Transplant Program in North Carolina

Duke Medicine has launched the first hand transplant program in North Carolina, becoming one of a small number of transplant centers in the country to offer the life-altering procedure.

Meningitis Model Shows Infection’s Sci-Fi-Worthy Creep Into the Brain

Scientists at Duke Medicine are using transparent fish to watch in real time as Cryptococcal meningitis takes over the brain. The resulting images are worthy of a sci-fi movie teaser, but could be valuable in disrupting the real, crippling brain infection that kills more than 600,000 people worldwide each year.

DART Protein Shows Potential as Shock-and-Kill Strategy Against HIV

A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system’s killer T cells. It could become a key part of a shock-and-kill strategy being developed in the hope of one day clearing HIV infection.

 « Previous 10 Page of 27 Next 10 »